UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 4
May-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1905V41


Registration ID:
310609

Page Number

3212-3220

Share This Article


Jetir RMS

Title

A STUDY OF CELL-CYCLE SURVIVAL WITH REGULATORS IN DUAL FUNCTIONS OF LUNGS CANCER

Abstract

Lung cancer is the leading cause of cancer death worldwide. Histologically, 80% of lung cancers are classified as non-small cell lung cancer (NSCLC), and the remaining 20% as small-cell lung cancer (SCLC). Lung carcinoma is the result of molecular changes in the cell, resulting in the deregulation of pathways controlling normal cellular growth, differentiation, and apoptosis. This review summarizes some of the most recent findings about the role of cell-cycle proteins in lung cancer pathogenesis and progression. The mammalian cell cycle is important in controlling normal cell proliferation and the development of various diseases. Cell cycle checkpoints are well regulated by both activators and inhibitors to avoid cell growth disorder and cancerogenesis. Cyclin dependent kinase 20 (CDK20) and p21Cip1/Waf1 are widely recognized as key regulators of cell cycle checkpoints controlling cell proliferation/growth and involving in developing multiple cancers. Emerging evidence demonstrates that these two cell cycle regulators also play an essential role in promoting cell survival independent of the cell cycle, particularly in those cells with a limited capability of proliferation, such as cardiomyocytes. These findings bring new insights into understanding cytoprotection in these tissues. Here, we summarize the new progress of the studies on these two molecules in regulating cell cycle/growth, and their new roles in cell survival by inhibiting various cell death mechanisms. We also outline their potential implications in cancerogenesis and protection in heart diseases. This information renews the knowledge in molecular natures and cellular functions of these regulators, leading to a better understanding of the pathogenesis of the associated diseases and the discovery of new therapeutic strategies.

Key Words

Cell cycle; CDK20; p21Cip1/Waf1; cancer; cardiovascular disease

Cite This Article

"A STUDY OF CELL-CYCLE SURVIVAL WITH REGULATORS IN DUAL FUNCTIONS OF LUNGS CANCER ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 4, page no.3212-3220, April-2019, Available :http://www.jetir.org/papers/JETIR1905V41.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A STUDY OF CELL-CYCLE SURVIVAL WITH REGULATORS IN DUAL FUNCTIONS OF LUNGS CANCER ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 4, page no. pp3212-3220, April-2019, Available at : http://www.jetir.org/papers/JETIR1905V41.pdf

Publication Details

Published Paper ID: JETIR1905V41
Registration ID: 310609
Published In: Volume 6 | Issue 4 | Year May-2019
DOI (Digital Object Identifier):
Page No: 3212-3220
Country: Sehore, MadhyaPradesh, India .
Area: Biological Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000356

Print This Page

Current Call For Paper

Jetir RMS